About Drew Scientific
Drew Scientific is a medical device company. It had developed the D3 Hematology Analyzer, Model D3.Drew Scientific designs and manufactures analytical instruments for Clinical Hematology, Veterinary Hematology, and HbA1c analysis for Diabetes. In October 2012, Drew Scientific was acquired by Transasia Bio-Medicals. The valuation of Drew Scientific was undisclosed. Other terms of the deal were not released.
Missing: Drew Scientific's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Drew Scientific's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Drew Scientific
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Drew Scientific is included in 1 Expert Collection, including Diabetes.
Drew Scientific Patents
Drew Scientific has filed 2 patents.
Avionics, Applications of computer vision, Engine technology, Computer vision, Video signal
Avionics, Applications of computer vision, Engine technology, Computer vision, Video signal
Latest Drew Scientific News
Jan 27, 2023
Major Players IDEXX, VetScan, Abaxis, Clindiag Systems, Boule Medical, Woodley Equipment, Sysmex, Siemens Healthineers, Drew Scientific, Diatron MI, HemoCue, Heska, Mindray Medical International, HORIBA Medical, Urit Medical, Qreserve, Rayto Life and Analytical Sciences. among other Segmentation Analysis The tabletop analyzers segment is expected to be the fastest-growing segment in 2022. The product type segment is divided into tabletop analyzers and point-of-care analyzers. The tabletop analyzers are further divided into fully automatic and semiautomatic analyzers. The point-of-care analyzers are further divided into cartridge-based and direct sample-based analyzers. The tabletop analyzers segment will witness the highest growth rate during the forecast period. Tabletop analyzers offer a thorough, comprehensive analysis. They are easy to use. Because there are so few sample requirements, it is quite compatible in a volatile environment. Low-maintenance instruments called tabletop analyzers are often employed in veterinary medicine. The growing animal population and the spread of diseases have increased the market demand for tabletop analyzers. Both fully automatic and semiautomatic analyzers dominate the market for tabletop analyzers. They offer a comprehensive analysis with superb precision. The 3-part WBC differential segment is expected to be the fastest-growing segment in 2022. The analysis parameter segment is divide into 2-part WBC differential, 3-part WBC differential, 5-part WBC differential and others. The 3-part WBC differential segment is expected to witness the highest growth rate during the forecast period. A 3-part WBC differential can be used to calculate the blood's concentration of monocytes, neutrophils, and lymphocytes. These analyzers are common in medical or veterinary hospitals, clinics, and diagnostic labs. They are popular in the veterinary field because they offer sufficient diagnostic data to pinpoint the ailment or condition plaguing the animal or pet. It works well and quickly to identify viral and bacterial infections. Due to the high prevalence of zoonotic diseases, primarily bacterial or viral, the market utilisation of 3-part WBC differential analyzers is growing. The veterinary hospitals and clinics segment is expected to be the fastest-growing segment in 2022. The end-user segment is divided into research institutes, veterinary hospitals and clinics, veterinary diagnostic centers, point-of-care testing, inhouse-testing, and others. The veterinary hospitals and clinics segment is expected to witness the highest growth rate during the forecast period. Since hospitals and clinics are the primary healthcare providers worldwide and are regarded in high regard by the general public, individuals usually turn to them first for their pets and domesticated animals. Veterinarian hospitals and clinics have all the supplies needed to provide the finest care for animals, including the medications, equipment, and other necessities. The increase in pet adoption has also led to the opening and operation of veterinary hospitals and clinics by both public and private actors to offer veterinary healthcare services to anyone in need. The opening of walk-in clinics with trained employees on hand to assist the patients coming in will hasten the growth of this industry. Regional Analysis The regional analysis provides a detailed perception of the key regions and the countries. Some of the key countries analyzed for the veterinary hematology analyzers include the US, Canada, Mexico, Germany, France, the U.K., Italy, Spain, Russia, China, Japan, India, Brazil, Peru, UAE, South Africa, and Saudi Arabia. The North America region witnessed a major share. There are a lot of meat eaters in the area. The regional cuisine of the North American market consumes a lot of meat. Commercial animal breeding is required to supply top-notch animal health, meet the demands of the sizable meat-eating populace, and safeguard consumer interests. The North American market has expanded as a result of stringent governmental rules and several organisations dedicated to the health and wellbeing of animals. The COVID-19 pandemic demonstrates the need for increased zoonotic disease incidence monitoring in order to prevent catastrophic destruction. Country Analysis Germany Germany's veterinary hematology analyzers market size was valued at USD 79.05 million in 2022 and is expected to reach USD 145.23 million by 2030, at a CAGR of 7.9% from 2023 to 2030. The demand for veterinary haematology analyzers is anticipated to rise as awareness of animal diseases increases, animal healthcare facilities are used more frequently, and the companion insurance healthcare programme implemented in Germany to enhance the effectiveness of the country's animal healthcare systems. China China’s veterinary hematology analyzers market size was valued at USD 55.25 million in 2022 and is expected to reach USD 100.01 million by 2030, at a CAGR of 7.7% from 2023 to 2030. The increasing incidence of meat consumption, growing worry over zoonotic illnesses, and the rapidly growing animal healthcare sector are all aspects that will help the market in the nation. The increasing number of cattle in the nation and the high incidence of pet adoption are also significant factors propelling the veterinary haematology analyzer market. India India's veterinary hematology analyzers market size was valued at USD 42.5 million in 2022 and is expected to reach USD 76.36 million by 2030, at a CAGR of 7.6% from 2023 to 2030. Modern veterinary haematology analyzers are in high demand due to the country's rapid increase in the prevalence of lifestyle diseases in dogs and cats, including as obesity and diabetes, which is driving the market's expansion. Covid-19 Impact Covid-19 had a major impact on almost all industries, such as electronics, semiconductors, manufacturing, automobile, etc. However, several companies operating in the technology sector have seen increased revenue due to significant changes in consumer preferences toward technological services. In addition, the pandemic has led to significant growth in technology across developing and developed countries. Furthermore, the growth of the veterinary hematology analyzers market is mainly driven by the increase in incidences of zoonotic diseases. Buy Now Full Report @ https://greyviews.com/checkout/469/single_user_license Contact Us Browse Related Reports: Veterinary Hematology Analyzers Market Size By Product Type (Table Top Analyzers (Fully Automatic Analyzers and Semiautomatic Analyzers) and Point of Care Analyzers (Cartridge-Based Analyzers and Direct Sample Based Analyzers), By Analysis Parameter (2-Part WBC Differential, 3-Part WBC Differential, 5-Part WBC Differential, and Others), By End-User (Research institutes, Veterinary hospitals and clinics, Veterinary diagnostic centers, point-of-care testing, inhouse-testing, and others), Regions, Segmentation, and Projection till 2030 Structural Heart Devices Market Size By Indication (Atrial Septal Defects, Aortic Valvular Disease, Pulmonary Valvular Disease, Patent Foramen Ovale, Ventricular Septal Defects, Mitral Valvular Disease, Patent Ductus Arteriosus, and Others), By Product Type (Heart Valve Devices, Annuloplasty Rings, Occluders and Delivery Systems, Transcatheter Mitral Valve Repair, and Others), By Procedure(Repair and Replacements), Regions, Segmentation, and Projection till 2030 Shoulder Arthroplasty Market Size By Indication (Arthritis, Fracture/Dislocation, Rotator Cuff Tear Arthropathy, Hill Sachs Defect, and Others), By Device (Shoulder Arthroplasty Resurfacing Implants, Shoulder Arthroplasty Trauma Devices, and Shoulder Arthroplasty Platform Systems), By Procedure (Partial Shoulder Arthroplasty, Total Shoulder Arthroplasty, Reverse Shoulder Arthroplasty, and Revision Shoulder Arthroplasty), Regions, Segmentation, and Projection till 2030
Drew Scientific Frequently Asked Questions (FAQ)
Where is Drew Scientific's headquarters?
Drew Scientific's headquarters is located at 4230 Shilling Way, Dallas.
What is Drew Scientific's latest funding round?
Drew Scientific's latest funding round is Acquired.
Who are the investors of Drew Scientific?
Investors of Drew Scientific include Transasia Bio-Medicals and New England Partners.
Who are Drew Scientific's competitors?
Competitors of Drew Scientific include SynCardia Systems, Abaxis, GlySure, Fenwal, Nuwellis and 10 more.
Compare Drew Scientific to Competitors
Pulse Metric designs, manufactures and markets products and services that transform a simple blood pressure reading into a powerful functional profile of the patients cardiovascular system, including cardiac output, vessel compliance, vascular resistance and left ventricular contractility. Within a minute of uploading a DynaPulse blood pressure waveform to the DynaPulse Analysis Center website, 17 hemodynamic parameters are calculated, displayed and trended, providing clinicians with numeric values profiling the hearts pumping performance, blood vessel elasticity and vascular resistance, against normative ranges.The company believes the simplicity of its methodology and the significance of the information provided to the physician will improve quality of care while reducing costs. Pulse Metric has been granted nine patents in support of its proprietary technology.
Spineworks Medical, Inc. designs and manufactures medical devices for spinal surgery.
Alara is a medical device company. It had developed the Alara T210 Computed Radiography System.Alara, Inc - Computed Radiography Products
Nephrologix Inc. is a private company that develops, manufactures and markets peritoneal dialysis (PD) systems.
Realistic Eye aims to provide a more natural appearance for the 750,000 patients in the US with an artificial eye that does not dilate and therefore appears unnatural. RealisticEye achieves these results by introducing a dilating artificial eye.
Zounds designs, manufactures, and markets high performance hearing aids for use with mild, moderate, and moderate/severe hearing impairments. Zounds' goal is to offer a portfolio of hearing aids and wireless devices that provide the world's best performing technology at an affordable price to anyone with a mild, moderate, or moderate/severe hearing loss.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.